Manifestasi Klinis Neurologis Pada Covid-19

Vania, Aurelia; Yuliani, Desie; Sumada, I Ketut

doi:10.29342/cnj.v3i3.118

Cited by 4 publications

(5 citation statements)

References 31 publications

(71 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…patients occurs due to significant damage to the nucleus of olfactory epithelial cells due to infection of supporting cells and vascular pericytes of the epithelium and olfactory bulb [9], [17]. [1], [7], [15], [19]. Another hypothesis suggests that anosmia occurs due to neuronal death caused by a cytokine storm, specifically the role of IL-6 produced by neurons through stimulation of the SARS-CoV-2 virus spike protein [1], [4]- [6], [20].…”

Section: Resultsmentioning

confidence: 99%

Decreased Body Mass Index (BMI) in COVID-19 Patients with Anosmia Symptoms

Ristanto,

Murtadho

2024

Babali Nurs. Res.

View full text Add to dashboard Cite

Introduction: COVID-19 is a respiratory infection caused by the SARS-CoV-19 virus and impacts the appearance of anosmia symptoms. Anosmia impacts reducing appetite, so it impacts fulfilling the nutritional needs of COVID-19 patients. This study aims to determine the effect of anosmia on the nutritional status of COVID-19 patients. Methods: This study is an observational study with a retrospective cohort design. The samples of this study were 48 health record data of COVID-19 patients who experienced anosmia in Karangploso View Housing, Malang Regency, from July to December 2021, selected according to the inclusion and exclusion criteria. The independent variable in this study is the incidence of anosmia felt by residents. The dependent variable is residents' Body Mass Index (BMI) before and after recovering from COVID-19 infection. This study was conducted from July 15 to August 11, 2023. Research data analysis using the SPSS version 22 program using the paired T-test and Wilcoxon test with α = 5%. Results: The paired T-test results on the weight variable showed a significant difference in the patient's weight between before and after COVID-19 illness with symptoms of anosmia (p-value = 0.000). The results of the Wilcoxon Test on the BMI variable showed a significant difference in the nutritional status (BMI) of respondents between before and after COVID-19 illness with symptoms of anosmia (p-value = 0.000). Conclusion: The condition of anosmia alters a person's food preferences, resulting in the perception of certain foods as less pleasant, bland, and unappealing. This condition results in loss of appetite, inadequate nutrient intake, and potential malnutrition. Self-efforts to prevent malnutrition due to anosmia in COVID-19 patients: using aromatic herbs and spices, eating small and frequent meals, modifying food texture and color seasoning, and consulting a dietician to develop a balanced and nutrient-rich meal plan.

show abstract

Section: Resultsmentioning

confidence: 99%

Decreased Body Mass Index (BMI) in COVID-19 Patients with Anosmia Symptoms

Ristanto,

Murtadho

2024

Babali Nurs. Res.

View full text Add to dashboard Cite

show abstract

“…A study reported the prevalence of altered consciousness in COVID-19 patients ranging from 1.4% to 6.9%, with a higher incidence in patients with comorbidities or critical conditions. Altered consciousness was associated with various causes such as encephalopathy, sepsis, and metabolic disorders [ 28 ]. This study demonstrated a relationship between sex with myopathy and altered consciousness, whereas there was no association between age with myopathy and altered consciousness.…”

Section: Discussionmentioning

confidence: 99%

“…In confirming the results, a study found that the most common neurological symptom among COVID-19 patients was headache, occurring in at least 6.5% of cases. Headaches can also manifest as the initial and only symptom in infected individuals [19,20,[23][24][25][26][27][28][29][30]. Additionally, a study reported a prevalence of approximately 12% for headaches among COVID-19 patients, with many patients encountering headaches as their initial symptom.…”

Section: Short Communicationmentioning

confidence: 99%

Neurological manifestations of COVID-19 in Indonesia: Assessment of the role of sex and age

Sompa,

Harun,

Mimika

et al. 2023

Narra J

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can manifest in multiple organs. While the primary manifestations of COVID-19 occur in the respiratory system, other organ systems are also involved, including nervous systems that cause neurological symptoms. The aim of this study was to determine the neurological manifestations of COVID-19 patients and to assess the role of age and sex on neurological manifestation incidence. A cross-sectional study was conducted at Pelamonia Hospital, Makassar, Indonesia, among inpatient COVID-19 cases, using a total sampling method. Demographic data and neurological manifestations of the COVID-19 patients were collected. The associations between age and sex with the incidence of neurological symptoms were analyzed using the Chi-squared test. Out of 424 inpatients with COVID-19 cases, 62.3% were females, with the highest age group was 20–40 years (42.7%). The neurological symptoms were reported in 232 patients, accounting for approximately 54.7%. The most frequently reported neurological symptom was headache (n=104, 44.8%), followed by anosmia (n=44, 18.9%), ageusia (n=48, 20.6%), myopathy (n=14, 6%), stroke (n=10, 4.3%), seizure (n=5, 2.1%), and altered consciousness (n=7, 3%). An association was found between sex and the incidence of headache, myopathy, stroke, and altered consciousness. There was also an association between age and the incidence of headache and stroke. The study highlights that COVID-19 patients commonly exhibit neurological implications affecting the central nervous system and peripheral nervous system. Therefore, it is crucial for the early detection of neurological symptoms in COVID-19 cases to have better management.

show abstract

“…SARS-CoV-2, also known as the coronavirus, is a disease that spreads quickly and can lead to pandemic circumstances. Infection with SARS-CoV-2 primarily manifests as respiratory system diseases [1]. Gas exchange during respiration includes the exchange of carbon dioxide (CO2) and oxygen (O2), which the body needs for cellular metabolism [2].…”

Section: Introductionmentioning

confidence: 99%

Design of a Covid-19 Patient Respiration Monitoring System Using an ESP 32 Microcontroller and an MPU 6050 Sensor for the Internet of Medical Things (IoMT) System

Hanifudin Tahier,

Azam,

Ketut Umiati

2023

Int J Res Rev

View full text Add to dashboard Cite

The main manifestation of COVID-19 disease infection is caused by respiratory system disorders. Periodic monitoring is needed to support good care and prevent complications caused by the slow response of nurses to the decline of the patient's clinical condition based on several physiological parameters in the National Early Warning Score COVID-19. This aim of this research is to build, design, and implement data acquisition systems on respiration sensors in a monitoring system or monitoring periodically based on the Internet of Medical Things (IoMT). The sensor that used to calculate the respiration cycle is the MPU6050 sensor by measuring the magnitude of the vibration. Sensor-scalable data will be acquired by the ESP32 microcontroller and sent to data storage on a computer over a W-Fi network in real time using the MQTT (Message Queuing Telemetry Transport) communication protocol and displayed in a web-based interface. The system that has been built runs well that can calculate the value of the respiration cycle per minute from patients with a small average deviation value of 1.26 % from manual calculations using stopwatches. Periodic monitoring can also be done with an average response time of 03.48 seconds. Keywords: ESP32 microcontroller, respiration cycle, COVID-19, MQTT

show abstract

Manifestasi Klinis Neurologis Pada Covid-19

Cited by 4 publications

References 31 publications

Decreased Body Mass Index (BMI) in COVID-19 Patients with Anosmia Symptoms

Decreased Body Mass Index (BMI) in COVID-19 Patients with Anosmia Symptoms

Neurological manifestations of COVID-19 in Indonesia: Assessment of the role of sex and age

Design of a Covid-19 Patient Respiration Monitoring System Using an ESP 32 Microcontroller and an MPU 6050 Sensor for the Internet of Medical Things (IoMT) System

Contact Info

Product

Resources

About